PRIME Cohort Studies

The cohort studies are treatment cohorts which assessed the clinical, social and economic outcomes of patients who have
received a diagnosis of depression, alcohol use disorder (AUD), psychosis or epilepsy. In some countries a control group
(patients who screen positive for a disorder but were undiagnosed by a clinician) were also followed up. Key research
themes included social, health and economic outcomes, equity of access, and stigma, discrimination, adherence and
retention in care. After the baseline data collection, patients were followed-up after 3 or 6 months (midline visit), and
again 12 months after the baseline (endline visit). A detailed description of the cohort methods has been published in
BMC Psychiatry (https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-018-1642-x). Below is a brief
overview of the design, recruitment and data collection methods.
If you wish to access the cohort dataset, please complete an expression of interest form at
https://docs.google.com/forms/d/e/1FAIpQLSfp9sVy_OKV18AWJfUlBGVnC_QuLyCalR4xVJR4tAMRR5g1wg/viewform.